SamaCare, a prior authorization platform for physician-administered medications, announced the close of a $12 million Series A funding round led by Clearlake Capital-backed Vive Collective, with participation from existing investors including NextView Ventures, South Park Commons, and Susa Capital.

SamaCare helps pharmaceutical manufacturers, providers, payors, and other stakeholders quickly and cost-effectively deliver life-changing therapies to patients. The company provides a cloud-based workflow automation platform for medical practices to streamline specialty drug prior authorization, enrollment, and benefit verification. In addition, SamaCare delivers premium services and data analytics for pharmaceutical brands to improve access to therapy.